Covid 19 Booster Update
A bivalent Covid 19 vaccine is coming sooner than expected. It was forecast for the fall. I thought it would be middle to late fall, but now it is said to be coming next month! The new vaccine would be…
A bivalent Covid 19 vaccine is coming sooner than expected. It was forecast for the fall. I thought it would be middle to late fall, but now it is said to be coming next month! The new vaccine would be…
As I mentioned in a previous post, small molecule treatments for viral illnesses, those that can be put in a pill, take years to develop. Large molecule treatments like monoclonal antibodies are easier to develop quickly, but less convenient to…
This is a practical advice on what do and what to expect when recovering from Covid 19. Everyone is different, which makes it hard to make recommendations. I thought this article from The Wall Street Journal had some reasonable advice.…
Here is an interesting article from the New York Times from a virologist who sheds insight on variants, vaccines and what virologists think about what the future holds. Did you know that hippos can get Covid 19? I knew that…
Not yet, but you should be concerned. I’m uneasy whenever an existing virus suddenly increases, or a novel virus abruptly appears. Some people think they don’t need to be bothered because it has only been reported in men who have…
Here is an article from this morning’s New York Times which is a nice summary of where we are. If you have not had a second booster, get one. Don’t wait until the mid-fall when a newer vaccine is supposed…
Here are several recent articles from the Wall Street Journal on the treatment and prevention of Covid 19. Bottom Line: We will run out of monoclonal antibody treatment in late August. If the government doesn’t pay for it, will you…
Sicilians, along with other Italians continue to emphasize outdoor dining to limit the spread of Covid 19. Above is a street in Noto, Sicily. I’m not home but my phone is still ringing. Never a good sign. Now things continue…
Here is an article from the New York Times about yesterday’s meeting of the FDA vaccine committee. It looks like the concensus was to develop a vaccine that targets Omicron variants, BA 4 and 5, not just Omicron. That is…